Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-2421

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71335-2421). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

This is a list of chemical compounds that may be used in pharmaceuticals or research. It includes NICHy, Hyc0 HCI, and venlafaxine hydrochloride.*

FDA Label Image

Image-02 (Image 02)

This appears to be a list of special populations with various conditions such as hepatic impairment, renal impairment, age over 80 years, and genetic polymorphisms. In addition, it mentions a list of analytes such as venlafaxine and provides information on fold change and confidence intervals. The text seems to include information related to pharmacokinetics and changes in analyte levels relative to a reference value.*

FDA Label Image

Image-03 (Image 03)

This document appears to be a list showing the interactions between different drugs and the analyte PK Fold Change along with the 90% Confidence Interval. The drugs mentioned include Ethanol, Venlafaxine, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, and Lithium. The measurements provided include Cmax and AUC values for the respective drug interactions. The table also indicates the change relative to the reference value.*

FDA Label Image

Image-04 (Image 04)

This text appears to be a list of interacting drugs, including examples such as Ethanor, Diazepam, Alprazolam, Haloperidol, and others. The text also contains analytes such as ethanol, desipramine, and caffeine among others. Additionally, it mentions fold change and 90% confidence interval associated with these substances.*

FDA Label Image

Label (Lbl713352421)

This is a pharmaceutical description of an extended-release capsule containing Venlafaxine Hydrochloride. It warns to keep the medication out of reach of children, store it in temperatures between 20°C to 25°C, advises that it may cause drowsiness, and indicates that it should be dispensed with a Medication Guide to each patient. The medication is manufactured by Bryant Ranch Prepack, Inc. and the NDC number is 71335-2421-1. For more information, visit the daily med website provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.